Qure's AMT-130 shows 80% Huntington's Disease progression slowing. Click to read more on QURE's financially strong, advancing ...

Choose from Pharmaceutical Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

She reiterated her buy recommendation on Vertex stock, and kept her $583-per-share ... part of a broader dive into the current state of pharmaceutical stocks by investment bank Cantor Fitzgerald.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Regeneron signs $3 billion deal with FUJIFILM to expand biologics manufacturing in North Carolina, boosting U.S. capacity and ...

Cyclacel Pharmaceuticals has amended a securities purchase agreement with interim CEO David Lazar, allowing the company to direct Lazar to purchase up to $8 million of its common stock in private ...

April 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica ... in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

In this article, we are going to take a look at where Corvus Pharmaceuticals ... returns while investing in companies with depressed stock prices, caution is always of utmost importance.

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.